GERON CORP Increase (Decrease) in Other Operating Liabilities
GERON CORP (GERN) reported Increase (Decrease) in Other Operating Liabilities of $8.74 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2020-11-05
- GERON CORP increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was $4.88M, a 66.48% increase year-over-year.
- GERON CORP increase (decrease) in other operating liabilities for the quarter ending 2019-09-30 was $2.93M.
- GERON CORP increase (decrease) in other operating liabilities for the quarter ending 2012-09-30 was -$780.00K, a 176.17% decline year-over-year.
- GERON CORP increase (decrease) in other operating liabilities for the quarter ending 2012-06-30 was $1.79M, a 727.19% increase year-over-year.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month |
|---|---|---|---|
| 2020-09-30 | $4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.74M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.85M 10-Q · filed 2020-08-06 | ||
| 2019-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.86M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $1.93M 10-Q · filed 2020-08-06 | ||
| 2012-09-30 | -$780.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $1.01M derived: sum of 2 quarters · filed 2012-11-02 | -$768.00K 10-Q · filed 2012-11-02 |
| 2012-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $12.00K 10-Q · filed 2012-08-03 | |
| 2012-03-31 | -$1.78M 10-Q · filed 2012-05-07 | ||
| 2011-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $1.24M derived: sum of 2 quarters · filed 2012-11-02 | $1.40M 10-Q · filed 2012-11-02 |
| 2011-06-30 | $217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $371.00K 10-Q · filed 2012-08-03 | |
| 2011-03-31 | $154.00K 10-Q · filed 2012-05-07 | ||
| 2010-09-30 | $731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $1.03M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $302.00K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |